OBG ManagementWhich women are most likely to die from breast cancer—those screened annually starting at age 40, biennially starting at age 50, or not at all?October 29, 2013Gynecologic CancerBreast Cancer
OBG ManagementUSPSTF recommends tamoxifen or raloxifene to reduce breast cancer risk in high-risk patients October 24, 2013Gynecologic CancerBreast Cancer
Ob.Gyn. NewsBreast cancer hormone therapy may affect cognitive functionOctober 18, 2013MenopauseBreast Cancer
Ob.Gyn. NewsMany women with cancer not told about impaired fertility riskOctober 16, 2013Breast CancerReproductive EndocrinologyGynecologic Cancer
Ob.Gyn. NewsJumping the gun on contralateral prophylactic mastectomy?October 9, 2013Breast CancerGynecology
Ob.Gyn. NewsT-DM1 tops physician’s choice in advanced HER2-positive breast cancerOctober 8, 2013Breast Cancer
Ob.Gyn. NewsFalse-negative rate for sentinel nodes high after neoadjuvant chemotherapy October 7, 2013Breast Cancer
Ob.Gyn. NewsPertuzumab approved as first neoadjuvant treatment for breast cancer September 30, 2013Breast Cancer
Ob.Gyn. NewsBMN 673 monotherapy makes splash in BRCA-mutated ovarian, breast cancerSeptember 30, 2013Breast CancerGynecologic Cancer
Ob.Gyn. NewsEverolimus effective in women with early failure of adjuvant therapySeptember 25, 2013Breast Cancer
Ob.Gyn. NewsASTRO outlines five radiation oncology practices that should be curtailedSeptember 24, 2013Breast Cancer
Ob.Gyn. NewsUSPSTF breast cancer chemoprevention recommendations: We’re in this togetherSeptember 23, 2013Breast Cancer
